Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
M303972-250mg
|
250mg |
2
|
$35.90
|
|
|
M303972-1g
|
1g |
2
|
$116.90
|
|
|
M303972-5g
|
5g |
2
|
$351.90
|
|
Potent, cell-permeable carbonic anhydrase inhibitor
| Synonyms | HMS2093A05 | KBio2_002095 | Oprea1_161738 | Acetamide, N-(4-methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)- | SPECTRUM1503252 | BRN 0232387 | FLOSMHQXBMRNHR-QPJJXVBHSA-N | Prestwick1_000802 | 4-27-00-08221 (Beilstein Handbook Reference) | Methe |
|---|---|
| Specifications & Purity | Moligand™, ≥98% |
| Biochemical and Physiological Mechanisms | Methazolamide has a plasma half-life of 14 hours in humans. Methazolamide has relatively good lipid solubility and low plasma protein binding ability. Thus, it diffuses into tissues and fluids much more readily than acetazolamide, another carbonic anhydra |
| Storage Temp | Store at -20°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Grade | Moligand™ |
| Action Type | INHIBITOR |
| Mechanism of action | Inhibitor of carbonic anhydrase 1;Inhibitor of carbonic anhydrase 12;Inhibitor of carbonic anhydrase 14;Inhibitor of carbonic anhydrase 4;Inhibitor of carbonic anhydrase 7 |
| Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
| Product Description |
Methazolamide (L584601) is a sulfonamide derivative used as a carbonic anhydrase inhibitor with a Ki of 14 nM for human carbonic anhydrase II. Methazolamide, an intraocular pressure-lowering agent, reduces intraocular pressure elevations associated with glaucoma and other ocular disorders |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Azoles |
| Subclass | Thiadiazoles |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Thiadiazole sulfonamides |
| Alternative Parents | Organosulfonamides Heteroaromatic compounds Aminosulfonyl compounds N-acylimines Carboxylic acids and derivatives Azacyclic compounds Organopnictogen compounds Organic oxides Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aromatic heteromonocyclic compounds |
| Substituents | 1,3,4-thiadiazole-2-sulfonamide - Organosulfonic acid amide - Organic sulfonic acid or derivatives - Organosulfonic acid or derivatives - Sulfonyl - Heteroaromatic compound - Aminosulfonyl compound - N-acylimine - Carboxylic acid derivative - Azacycle - Carbonyl group - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Organic oxygen compound - Organosulfur compound - Organooxygen compound - Organonitrogen compound - Organic nitrogen compound - Aromatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as thiadiazole sulfonamides. These are heterocyclic compounds containing a thiazole ring substituted by at least one sulfonamide group. |
| External Descriptors | Not available |
|
|
|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Pubchem Sid | 504750745 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504750745 |
| IUPAC Name | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide |
| INCHI | InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12) |
| InChIKey | FLOSMHQXBMRNHR-UHFFFAOYSA-N |
| Smiles | CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C |
| Isomeric SMILES | CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C |
| Molecular Weight | 236.3 |
| Reaxy-Rn | 232387 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=232387&ln= |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Aug 08, 2024 | M303972 | |
| Certificate of Analysis | Aug 08, 2024 | M303972 | |
| Certificate of Analysis | Dec 07, 2022 | M303972 | |
| Certificate of Analysis | Dec 07, 2022 | M303972 | |
| Certificate of Analysis | Dec 07, 2022 | M303972 |
| Solubility | DMSO: 20 mg/mL, clear |
|---|---|
| Sensitivity | light sensitive |
| Melt Point(°C) | 208°C |
| Molecular Weight | 236.300 g/mol |
| XLogP3 | 0.100 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 1 |
| Exact Mass | 236.004 Da |
| Monoisotopic Mass | 236.004 Da |
| Topological Polar Surface Area | 139.000 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 419.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
| 1. Junrong Li, Yingjun Wang, Ziqi Fan, Panyang Tang, Mengting Wu, Hong Xiao, Zhenxing Zeng. (2023) Toxicity of Tetracycline and Metronidazole in Chlorella pyrenoidosa. International Journal of Environmental Research and Public Health, 20 (4): (3623). |
| 2. Da Wang, Zhe Yang, Yinning He, Shiwen Dong, Feilong Dong, Zhiqiao He, Xiaohui Lu, Lizhang Wang, Shuang Song, Jun Ma. (2023) Metribuzin and metamitron degradation using catalytic ozonation over tourmaline: Kinetics, degradation pathway, and toxicity. SEPARATION AND PURIFICATION TECHNOLOGY, 309 (123028). |
| 3. Haojiang Wang, Wenli Hu, Qiong Zheng, Wei Bian, Zian Lin. (2017) One-pot preparation of mercaptotetrazole-silica hybrid monoliths by the thiol-ene click reaction for mixed-mode capillary liquid chromatography. JOURNAL OF SEPARATION SCIENCE, 40 (11): (2344-2354). |